US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist
  • 291.160
  • -3.430-1.16%
Close Feb 14 16:00 ET
  • 291.250
  • +0.090+0.03%
Post 20:01 ET
156.41BMarket Cap38.51P/E (TTM)

About Amgen Company

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Company Profile

SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees28000
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert A. Bradway
  • Chairman of the Board, President and Chief Executive Officer
  • 22.64M
  • Peter H. Griffith
  • Executive Vice President and Chief Financial Officer
  • 6.02M
  • Matthew C. Busch
  • Vice President, Finance and Chief Accounting Officer
  • --
  • Nancy A. Grygiel
  • Senior Vice President and Chief Compliance Officer
  • --
  • Dr. James E. Bradner, M.D.
  • Executive Vice President, Research and Development and Chief Scientific Officer
  • --
  • Dr. David M. Reese, M.D.
  • Executive Vice President and Chief Technology Officer
  • 7.90M
  • Jonathan P. Graham
  • Executive Vice President, General Counsel and Secretary
  • --
  • Esteban Santos
  • Executive Vice President, Operations
  • 7.21M
  • Rachna Khosla
  • Senior Vice President, Business Development
  • --
  • Derek Miller
  • Senior Vice President, Human Resources
  • --
  • Murdo Gordon
  • Executive Vice President, Global Commercial Operations
  • 8.24M
  • Professor Dr. Tyler E. Jacks, PhD
  • Independent Director
  • 339.92K
  • Amy E. Miles
  • Independent Director
  • 359.92K
  • Dr. Brian J. Druker, M.D.
  • Independent Director
  • 359.92K
  • Dr. S. Omar Ishrak
  • Independent Director
  • 366.47K
  • Michael V. Drake
  • Independent Director
  • 339.92K
  • Charles M. Holley, Jr
  • Independent Director
  • 369.92K
  • Robert A. Eckert
  • Lead Independent Director
  • 419.92K
  • Dr. Robert Sanders Willia M.D.
  • Independent Director
  • 360.86K
  • Ellen J. Kullman
  • Independent Director
  • 360.29K
  • Greg C. Garland
  • Independent Director
  • 379.92K
  • Dr. Ronald D. Sugar
  • Independent Director
  • 379.92K
  • Mary E. Klotman
  • Independent Director
  • --
  • Dr. Wanda M. Austin
  • Independent Director
  • 359.92K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!